Company Earnings Update 4 minutesRegister for Free AccessCVS Health (NYSE: CVS) 1Q19 Results: Strong Aetna Performance Boosts Revenues, Prompts Guidance Raise Coresight Research May 3, 2019 Executive Summary CVS Health reported 1Q19 revenues of $61.6 billion, ahead of the consensus estimate and up 34.8% year over year. Adjusted EPS was $1.62, up 9.5% year over year and above the consensus estimate. CVS closed its acquisition of Aetna in Novesmber 2018, so this is the first full quarter of combined operations. For FY19, CVS raised adjusted EPS guidance to $6.75-6.90 from $6.68-6.88. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: US Holiday Survey and Outlook 2023: E-Commerce To Drive GrowthOctober 2023 US Housing Market Indicators: Elevated Mortgage Rates Push Housing Sentiment Even LowerRetail Industry Analysis: What Can Retailers Learn from Shein and Temu?Weekly US and UK Store Openings and Closures Tracker 2024, Week 34: Full-Year Store Closures in the US To Exceed 5,000
